SLOW-RELEASE CHARACTERISTICS OF DILTIAZEM FROM ETHYLATED BETA-CYCLODEXTRIN COMPLEXES

被引:42
作者
HORIUCHI, Y [1 ]
HIRAYAMA, F [1 ]
UEKAMA, K [1 ]
机构
[1] KUMAMOTO UNIV,FAC PHARMACEUT SCI,5-1 OE HONMACHI,KUMAMOTO 862,JAPAN
关键词
D O I
10.1002/jps.2600790211
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Release characteristics of two ethylated β‐cyclodextrins [heptakis(2, 6‐di‐O‐ethyl)‐β‐cyclodextrin (diethyl‐β‐cyclodextrin) and heptakis(2, 3, 6‐tri‐O‐ethyl)‐β‐cyclodextrin (triethyl‐β‐cyclodextrin)] as sustained‐release drug carriers were evaluated using diltiazem hydrochloride, a water‐soluble calcium antagonist. The release rate of diltiazem from compressed tablets was significantly retarded by the complexation with ethylated β‐cyclodextrin. Various environmental effects (such as pH, rotating speed, and additive in the dissolution medium) on the release rate were investigated, together with a microscopic observation of the tablet surface. The water penetration rate into the tablet was measured in order to gain insight into the release mechanism. The results suggested that diltiazem is released slowly from the hydrophobic matrix consisting of diethyl‐β‐cyclodextrin following water penetration. When a single dose of tablets containing diethyl‐β‐cyclodextrin complex was orally administered to dogs, the sustained‐release pattern of the drug, without decrease in area under the plasma concentration–time curve, was produced for a long period. The release rate of diltiazem can be controlled by combining the ethylated β‐cyclodextrin complexes with the parent β‐cyclodextrin complex in different mixing ratios. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:128 / 132
页数:5
相关论文
共 21 条
[1]   DILTIAZEM HYDROCHLORIDE - SYNTHETIC AND PHARMACOLOGICAL STUDIES AND DEVELOPMENT [J].
ABE, K ;
INOUE, H ;
NAGAO, T .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1988, 108 (08) :716-732
[2]   PHYSICOCHEMICAL ASPECTS OF DRUG RELEASE .7. THE EFFECT OF SURFACTANT CONCENTRATION AND DRUG PARTICLE-SIZE ON SOLUBILITY AND DISSOLUTION RATE OF FELODIPINE, A SPARINGLY SOLUBLE DRUG [J].
ANDERBERG, EK ;
BISRAT, M ;
NYSTROM, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :67-77
[3]   IMPROVED GAS-CHROMATOGRAPHIC DETERMINATION OF DILTIAZEM AND DEACETYLDILTIAZEM IN HUMAN-PLASMA [J].
CLOZEL, JP ;
CAILLE, G ;
TAEYMANS, Y ;
THEROUX, P ;
BIRON, P ;
BESNER, JG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (02) :207-209
[4]   GASTROINTESTINAL TRANSIT OF A CONTROLLED-RELEASE PELLET FORMULATION OF TIAPROFENIC ACID AND THE EFFECT OF FOOD [J].
DAVIS, SS ;
KHOSLA, R ;
WILSON, CG ;
WASHINGTON, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 35 (03) :253-258
[5]   CLINICAL PHARMACOKINETICS OF VERAPAMIL, NIFEDIPINE AND DILTIAZEM [J].
ECHIZEN, H ;
EICHELBAUM, M .
CLINICAL PHARMACOKINETICS, 1986, 11 (06) :425-449
[6]   SQUARE ROOT OF TIME-DEPENDENCE OF MATRIX FORMULATIONS WITH LOW DRUG CONTENT [J].
FESSI, H ;
MARTY, JP ;
PUISIEUX, F ;
CARSTENSEN, JT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (07) :749-752
[7]   PHARMACOKINETICS OF DILTIAZEM AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
HERMANN, P ;
RODGER, SD ;
REMONES, G ;
THENOT, JP ;
LONDON, DR ;
MORSELLI, PL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (03) :349-352
[9]   UTILIZATION OF DIETHYL-BETA-CYCLODEXTRIN AS A SUSTAINED-RELEASE CARRIER FOR ISOSORBIDE DINITRATE [J].
HIRAYAMA, F ;
HIRASHIMA, N ;
ABE, K ;
UEKAMA, K ;
IJITSU, T ;
UENO, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (03) :233-236
[10]   THE PHARMACOKINETICS AND PHARMACOLOGY OF ORAL DILTIAZEM IN NORMAL VOLUNTEERS [J].
KINNEY, EL ;
MOSKOWITZ, RM ;
ZELIS, R .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :337-342